Submitted by Anonymous (not verified) on 10 July 2025 - 12:45
Human medicines European public assessment report (EPAR): Arikayce liposomal, amikacin, Date of authorisation: 27/10/2020, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Arikayce liposomal, amikacin, Date of authorisation: 27/10/2020, Revision: 3, Status: Authorised